Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Blackline Announces Closing of $40 Million Bought Deal Financing
-
PLBY Group, Inc. (PLBY) Acquisition Adds to its Creator Platform - Canaccord Genuity
-
AeroVironment (AVAV) Sensor to Shooter Test Demonstrates Drone Importance in Reducing Collateral Damage - Canaccord Genuity
-
Taiga Launches Revolutionary Off-Road Charging Network to Bolster Outdoor Exploration
-
Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
-
Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
-
Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
-
Canaccord Genuity Publishes Research Report on WonderFi
-
UPDATE: ChemoCentryx (CCXI) PT Raised to $65 at Canaccord Genuity After Management NDR
-
Calibre Mining Appoints Tom Gallo as Senior Vice President, Growth
-
Calibre Mining Appoints Tom Gallo as Senior Vice President, Growth
-
Paragon 28, Inc. Announces Pricing of Initial Public Offering
-
Paragon 28 (FNA) IPO Opens 20% Higher
-
Fountain Asset Corp. Announces Normal Course Issuer Bid
-
Paragon 28 (FNA) Prices 7.8M Share IPO at $16/sh
-
Paragon 28, Inc. Announces Pricing of Initial Public Offering
-
Tudor Gold Announces Upsizing of Previously Announced Private Placement Financing to $15 Million, with Participation by Eric Sprott
-
Lucid Diagnostics (LUCD) IPO Opens, Trades Lower
-
SpineGuard Reports Third-quarter 2021 Revenue
-
Global Decision Analytics Company Copperleaf Completes Initial Public Offering
-
UPDATE: Blue Origin Launches Shatner Into Space, Virgin Galactic (SPCE) Ticket Price of $450k May Be Too Low - Canaccord Genuity
-
Lucid Diagnostics Inc (LUCD) Prices 5M Share IPO at $14/sh
-
Lucid Diagnostics Announces Pricing of Initial Public Offering
-
Lucid Diagnostics Announces Pricing of Initial Public Offering
-
Lucid Diagnostics Announces Pricing of Initial Public Offering
-
UserTesting Files Registration Statement for Proposed Initial Public Offering
-
Workplace Technology Dividend Fund Files Final Prospectus
-
Arizona Sonoran Copper Company Files Preliminary Prospectus for Proposed Initial Public Offering
-
Western Exploration and Crystal Peak Minerals Announce Closing of Previously-Announced $6 Million Subscription Receipt Financing
-
good natured® Announces Pricing of Convertible Debenture Offering
-
Winc Announces Launch of Initial Public Offering
-
TransMedics Group (TMDX) KOL Call Takeaways - Canaccord Genuity
-
Neuronetics (STIM) PT Lowered to $15 at Canaccord Genuity
-
InMode Ltd. (INMD) PT Raised to $80 at Canaccord Genuity
-
HubSpot Inc (HUBS) PT Raised to $830 at Canaccord Genuity Following Analyst Day
-
Appgate, a Leading Cybersecurity Company Founded on Zero Trust Principles, Closes Merger with Newtown Lane Marketing
-
Aumento Capital VIII Corporation and Eddy Smart Home Solutions Inc. Announce Closing of Second Tranche of Brokered Private Placement
-
Taiga Reaches 110 Fleet Pre-Orders Worldwide for Orca and Snowmobile
-
Atalaya Mining PLC Announces Q3 2021 Operations Update and Increase in Guidance
-
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
-
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
-
Western Exploration and Crystal Peak Minerals Provide Update on Previously-Announced RTO Transaction, Including $6 Million Subscription Receipt Financing
-
ALX Resources Corp. Closes First Tranche of Private Placement for $2.85 Million
-
County Capital 2 Ltd. and Givex Corporation Announces $10 Million Private Placement in Connection with Qualifying Transaction
-
PharmaCann and LivWell Enlightened Health Announce Planned Merger
-
Rocket Lab USA (RKLB) Begins Launching Again in NZ - Canaccord Genuity
-
Evolent Health (EVH) PT Raised to $37 at Canaccord Genuity
-
Canaccord Genuity Starts Sportradar Group AG (SRAD) at Buy
-
Canaccord Genuity Starts Definitive Healthcare Corp (DH) at Hold
-
Bicycle Therapeutics (BCYC) PT Raised to $60 at Canaccord Genuity

